Riga, Latvia

Sanita Petkune

This inventor holds 1 USPTO granted patent. Top assignee: Eurovet Animal Health B.v.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sanita Petkune. Retrieved from https://idiyas.com/inventor/sanita-petkune

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sanita Petkune: Innovator in Pharmaceutical Composition

Introduction

Sanita Petkune is a notable inventor based in Riga, Latvia. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance therapeutic efficacy.

Latest Patents

Sanita holds a patent for "Crystalline pimobendan, process for the preparation thereof, pharmaceutical composition and use." This invention relates to a pharmaceutical composition containing pimobendan as an active ingredient. It also introduces a crystalline form of pimobendan, along with a combination of this crystalline form with at least one other therapeutically active ingredient. Furthermore, the invention outlines the uses of the crystalline form and details a process for preparing it.

Career Highlights

Sanita Petkune is associated with Eurovet Animal Health B.V., where she applies her expertise in pharmaceutical innovations. Her work focuses on improving animal health through advanced medicinal formulations.

Collaborations

Sanita has collaborated with notable professionals in her field, including Rudolf Johannes Paridaans and Marinus Maria Martinus Boeren. These collaborations have contributed to her success and the advancement of her inventions.

Conclusion

Sanita Petkune's innovative work in pharmaceutical compositions showcases her dedication to enhancing therapeutic options in veterinary medicine. Her contributions are vital to the ongoing development of effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…